×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Syros Pharmaceuticals Inc.. (SYRS) NASDAQ

$5.35 (0.49) (-8.39%)

Market Cap: $33.71M

As of 03/28/24 04:00 PM EDT. Market closed.

(SYRS)

Syros Pharmaceuticals Inc.. (SYRS)
NASDAQ

$5.35
(0.49) (-8.39%)

Market Cap: $33.71M

As of 03/28/24 04:00 PM EDT. Market closed.

Add to Portfolio

syros pharmaceuticals is a life sciences company that is focused on treating disease by mapping gene regulatory circuits and modulating the factors that regulate gene expression. syros has pioneered world-leading gene control research and drug discovery capabilities with a proven ability to integrate disease biology and genomic data--a proficiency that is not well represented in pharmaceutical ... read more

syros pharmaceuticals is a life sciences company that is focused on treating disease by mapping gene regulatory circuits and modulating the factors that regulate gene expression. syros has pioneered world-leading gene control research and drug discovery capabilities with a proven ability to integrate disease biology and genomic data--a proficiency that is not well represented in pharmaceutical r&d. central to the syros approach is a proprietary platform of carefully integrated assay technologies, bioinformatics, and biologic insights developed by members of syros' senior leadership. while this scientific approach has applications in many therapeutic areas, syros has demonstrated success initially in oncology, where it may help address numerous unmet medical needs. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO Compensation (Base)
$560,000
CEO Compensation (Total)
$3.03M
URL
Address
35 Cambridge Park Drive, Massachusetts, Cambridge, 02140.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Nancy Simonian
CEO Compensation (Base)
$560,000
CEO Compensation (Total)
$3.03M
Address
35 Cambridge Park Drive, Massachusetts, Cambridge, 02140.
PRICE CHART FOR SYROS PHARMACEUTICALS INC.
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$5.55
Previous Close
$5.84
Days Range
$5.15 - $5.90
52 week range
$2.09 - $8.17
Volume
318,254
Avg. Volume (30 days)
195,626
Market Cap
$33.71M
Dividend Yield
-
P/E
(1.35)
Shares Outstanding
6,300,529
Open
$5.55
Previous Close
$5.84
Days Range
$5.15 - $5.90
52 week range
$2.09 - $8.17
Volume
318,254
Avg. Volume (30 days)
195,626
Market Cap
$33.71M
Dividend Yield
-
P/E
(1.35)
Shares Outstanding
6,300,529
FINANCIAL STATEMENTS FOR SYROS PHARMACEUTICALS INC.
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR SYROS PHARMACEUTICALS INC.
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
AKKARAJU SRINIVASDirectorDec 21, 2023 Buy$4.42904,9773,999,9981,786,427Dec 26, 2023, 05:24 PM
Roth DavidChief Medical OfficerDec 12, 2023 Sale$4.956,28731,1210Dec 14, 2023, 04:24 PM
Roth DavidChief Medical OfficerDec 06, 2023 Sale$3.956,28724,8346,287Dec 08, 2023, 04:23 PM
Simonian Nancy APresident & CEONov 01, 2023 Option Exercise$2.2213,40129,750100,144Nov 02, 2023, 04:54 PM
Haas JasonChief Financial OfficerNov 01, 2023 Option Exercise$2.226,30113,98813,951Nov 02, 2023, 04:53 PM
Roth DavidChief Medical OfficerNov 01, 2023 Option Exercise$2.226,30113,98812,574Nov 02, 2023, 04:52 PM
Stephens KristinChief Development OfficerNov 01, 2023 Option Exercise$2.225,67612,60115,789Nov 02, 2023, 04:52 PM
Chee ConleyChief Commercial OfficerNov 01, 2023 Option Exercise$2.226,00413,32912,338Nov 02, 2023, 04:51 PM
Quirk Gerald EChief Legal & Compliance OfficOct 19, 2023 Option Exercise$2.106,89714,48424,303Oct 20, 2023, 04:23 PM
Roth DavidChief Medical OfficerJul 31, 2023 Sale$3.957,34829,0250Aug 02, 2023, 04:21 PM
Olson Eric RChief Scientific OfficerJul 17, 2023 Sale$3.506892,4126,661Jul 18, 2023, 08:27 PM
Haas JasonChief Financial OfficerApr 03, 2023 Option Exercise$2.586231,6071,377Apr 04, 2023, 06:57 PM
Chee ConleyChief Commercial OfficerApr 03, 2023 Option Exercise$2.586581,6981,342Apr 04, 2023, 06:56 PM
Roth DavidChief Medical OfficerApr 03, 2023 Option Exercise$2.586231,6077,348Apr 04, 2023, 06:56 PM
Stephens KristinChief Development OfficerApr 03, 2023 Option Exercise$2.586231,6074,465Apr 04, 2023, 06:55 PM
Olson Eric RChief Scientific OfficerApr 03, 2023 Option Exercise$2.586231,6077,350Apr 04, 2023, 06:54 PM
Simonian Nancy APresident & CEOApr 03, 2023 Option Exercise$2.581,8524,77873,420Apr 04, 2023, 06:54 PM
TYSON TIMOTHYDirectorSep 30, 2022 Buy$6.3714,00089,18624,932Oct 03, 2022, 04:42 PM
TYSON TIMOTHYDirectorSep 29, 2022 Buy$5.722,93216,77010,932Oct 03, 2022, 04:42 PM
Stephens KristinChief Development OfficerApr 01, 2022 Option Exercise$1.1214,11515,80930,885Apr 04, 2022, 05:04 PM
Roth DavidChief Medical OfficerApr 01, 2022 Option Exercise$1.1227,28130,55559,719Apr 04, 2022, 05:03 PM
Olson Eric RChief Scientific OfficerApr 01, 2022 Option Exercise$1.1227,26630,53859,734Apr 04, 2022, 05:02 PM
Simonian Nancy APresident & CEOApr 01, 2022 Option Exercise$1.1258,88365,949692,723Apr 04, 2022, 05:02 PM
Olson Eric RChief Scientific OfficerJan 05, 2022 Sale$3.472,2087,6550Jan 06, 2022, 05:02 PM
Olson Eric RChief Scientific OfficerJul 01, 2021 Sale$5.551,1646,4600Jul 01, 2021, 05:20 PM
Olson Eric RChief Scientific OfficerMar 15, 2021 Option Exercise$1.013,6283,6643,628Mar 17, 2021, 05:10 PM
Olson Eric RChief Scientific OfficerMar 15, 2021 Sale$9.473,62834,3720Mar 17, 2021, 05:10 PM
Young Richard ADirectorFeb 16, 2021 Sale$12.053,75045,188321,711Feb 18, 2021, 05:34 PM
Young Richard ADirectorFeb 08, 2021 Sale$13.043,75048,900325,461Feb 10, 2021, 05:29 PM
Young Richard ADirectorNov 17, 2020 Sale$8.755,35746,874329,211Feb 10, 2021, 05:28 PM
Young Richard ADirectorNov 16, 2020 Sale$8.986335,684334,568Feb 10, 2021, 05:28 PM
Simonian Nancy APresident & CEODec 18, 2020 Option Exercise$6.8129,917203,612563,606Dec 21, 2020, 04:58 PM
Young Richard ADirectorNov 17, 2020 Sale$8.755,35746,874339,211Nov 18, 2020, 04:33 PM
Young Richard ADirectorNov 16, 2020 Sale$8.986335,684344,568Nov 18, 2020, 04:33 PM
Young Richard ADirectorOct 19, 2020 Sale$8.755,67349,639335,201Oct 19, 2020, 06:36 PM
Young Richard ADirectorOct 15, 2020 Sale$8.753172,774340,874Oct 16, 2020, 04:39 PM
Young Richard ADirectorSep 15, 2020 Sale$10.395,99062,236341,191Sep 16, 2020, 08:32 AM
Olson Eric RChief Scientific OfficerAug 18, 2020 Option Exercise$1.0110,78710,89510,787Aug 19, 2020, 04:35 PM
Olson Eric RChief Scientific OfficerAug 17, 2020 Option Exercise$1.014,9635,0134,963Aug 19, 2020, 04:35 PM
Olson Eric RChief Scientific OfficerAug 17, 2020 Sale$13.004,96364,5190Aug 19, 2020, 04:35 PM
Olson Eric RChief Scientific OfficerAug 18, 2020 Sale$13.0010,787140,2310Aug 19, 2020, 04:35 PM
Young Richard ADirectorAug 17, 2020 Sale$12.595,99075,414347,181Aug 19, 2020, 04:33 PM
AKKARAJU SRINIVASDirectorAug 18, 2020 Sale$13.10158,5832,076,7241,274,616Aug 19, 2020, 04:03 PM
AKKARAJU SRINIVASDirectorAug 17, 2020 Sale$13.007449,6721,433,199Aug 19, 2020, 04:03 PM
Young Richard ADirectorJul 15, 2020 Sale$11.855,99070,982353,171Jul 17, 2020, 04:11 PM
Olson Eric RChief Scientific OfficerJul 07, 2020 Sale$11.721,75320,5380Jul 07, 2020, 07:33 PM
AKKARAJU SRINIVASDirectorJul 01, 2020 Sale$11.014,62750,9661,433,943Jul 06, 2020, 04:00 PM
AKKARAJU SRINIVASDirectorJun 25, 2020 Sale$11.1554,972612,8501,438,570Jun 25, 2020, 08:38 PM
AKKARAJU SRINIVASDirectorJun 24, 2020 Sale$11.0748,775539,7881,493,542Jun 25, 2020, 08:38 PM
AKKARAJU SRINIVASDirectorJun 23, 2020 Sale$11.1150,953565,9301,542,317Jun 25, 2020, 08:38 PM
Young Richard ADirectorJun 15, 2020 Sale$8.755,99052,413359,161Jun 16, 2020, 04:53 PM
Young Richard ADirectorMay 15, 2020 Sale$9.225,99055,242365,151May 15, 2020, 05:13 PM
Alles Mark JDirectorMay 13, 2020 Buy$8.8610,00088,59010,000May 13, 2020, 05:05 PM
Young Richard ADirectorApr 15, 2020 Sale$8.7523,960209,650371,141Apr 17, 2020, 04:02 PM
Olson Eric RChief Scientific OfficerFeb 18, 2020 Sale$7.381,44610,6740Feb 20, 2020, 04:15 PM
Simonian Nancy APresident & CEODec 23, 2019 Option Exercise$3.0452,401159,299533,689Dec 23, 2019, 04:54 PM
Springhorn Jeremy P.Chief Business OfficerNov 11, 2019 Buy$4.999,87949,32824,879Nov 12, 2019, 04:34 PM
Springhorn Jeremy P.Chief Business OfficerNov 12, 2019 Buy$4.9710,12150,26835,000Nov 12, 2019, 04:34 PM
Young Richard ADirectorAug 16, 2019 Sale$10.0022,700227,000395,101Aug 19, 2019, 04:08 PM
Young Richard ADirectorAug 15, 2019 Sale$10.002,30023,000417,801Aug 19, 2019, 04:08 PM
ARCH Venture Fund VII, L.P.10% OwnerJul 17, 2019 Sale$7.7034,521265,6874,242,051Jul 17, 2019, 07:26 PM
ARCH Venture Fund VII, L.P.10% OwnerJul 16, 2019 Sale$7.8125,779201,2774,276,572Jul 17, 2019, 07:26 PM
ARCH Venture Fund VII, L.P.10% OwnerJul 15, 2019 Sale$8.272,70022,3164,302,051Jul 17, 2019, 07:26 PM
AKKARAJU SRINIVASDirectorApr 09, 2019 Buy$7.50533,3323,999,9901,593,270Apr 11, 2019, 04:37 PM
ARCH Venture Fund VII, L.P.10% OwnerMar 14, 2019 Sale$8.1543,000350,4414,305,051Mar 14, 2019, 06:57 PM
ARCH Venture Fund VII, L.P.10% OwnerMar 13, 2019 Sale$7.9084,411666,5654,350,871Mar 14, 2019, 06:57 PM
ARCH Venture Fund VII, L.P.10% OwnerMar 12, 2019 Sale$7.3740,092295,3744,432,462Mar 14, 2019, 06:57 PM
ARCH Venture Fund VII, L.P.10% OwnerMar 11, 2019 Sale$6.4944,878291,3664,472,554Mar 11, 2019, 05:58 PM
ARCH Venture Fund VII, L.P.10% OwnerMar 08, 2019 Sale$6.9384,496585,2704,517,432Mar 11, 2019, 05:58 PM
ARCH Venture Fund VII, L.P.10% OwnerMar 07, 2019 Sale$6.8735,209242,0134,601,928Mar 11, 2019, 05:58 PM
Simonian Nancy APresident & CEONov 29, 2018 Option Exercise$1.23110,588136,224481,288Dec 03, 2018, 04:06 PM
AKKARAJU SRINIVASDirectorJan 31, 2018 Buy$9.55209,4241,999,9991,059,938Feb 02, 2018, 03:53 PM
Springhorn Jeremy P.Chief Business OfficerDec 15, 2017 Buy$9.0815,000136,26015,000Dec 15, 2017, 04:02 PM
AKKARAJU SRINIVASDirectorDec 14, 2017 Buy$8.9926,600239,134830,494Dec 14, 2017, 08:22 PM
AKKARAJU SRINIVASDirectorDec 13, 2017 Buy$8.9768,400613,548803,894Dec 14, 2017, 08:22 PM
AKKARAJU SRINIVASDirectorDec 12, 2017 Buy$9.4014,774138,876735,494Dec 14, 2017, 08:22 PM
DeSimone Colleen ElizabethPrincipal Accounting OfficerOct 23, 2017 Option Exercise$3.045501,672550Oct 23, 2017, 04:44 PM
DeSimone Colleen ElizabethPrincipal Accounting OfficerOct 23, 2017 Sale$16.065508,8330Oct 23, 2017, 04:44 PM
Young Richard ADirectorAug 14, 2017 Sale$22.003,28272,204420,101Aug 16, 2017, 04:08 PM
Olson Eric RChief Scientific OfficerAug 07, 2017 Option Exercise$1.012,5002,5252,500Aug 08, 2017, 05:20 PM
Olson Eric RChief Scientific OfficerAug 07, 2017 Sale$23.592,50058,9690Aug 08, 2017, 05:20 PM
Olson Eric RChief Scientific OfficerJul 25, 2017 Option Exercise$1.0112,50012,62512,500Jul 27, 2017, 04:09 PM
Olson Eric RChief Scientific OfficerJul 25, 2017 Sale$21.8512,500273,1250Jul 27, 2017, 04:09 PM
Young Richard ADirectorJul 25, 2017 Sale$22.093,28272,496423,383Jul 27, 2017, 04:09 PM
Nashat AmirDirectorJul 06, 2016 Buy$12.50400,0005,000,0001,538,333Jul 07, 2016, 05:41 PM
Polaris Management Co. VII, L.L.C.10% OwnerJul 06, 2016 Buy$12.50400,0005,000,0001,538,333Jul 07, 2016, 05:41 PM
Flagship Ventures Fund IV, L.P.10% OwnerJul 06, 2016 Buy$12.50400,0005,000,0003,674,660Jul 07, 2016, 06:04 AM
Redmile Group, LLC10% OwnerJul 06, 2016 Buy$12.50432,7465,409,325366,739Jul 07, 2016, 06:03 AM
Arch Venture Fund VII LP10% OwnerJul 06, 2016 Buy$12.50400,0005,000,0004,637,137Jul 07, 2016, 06:02 AM
NELSEN ROBERTDirectorJul 06, 2016 Buy$12.50400,0005,000,0004,637,137Jul 06, 2016, 09:22 PM
AISLING CAPITAL III LP10% OwnerJul 06, 2016 Buy$12.50400,0005,000,000908,565Jul 06, 2016, 05:10 PM
Flynn James E10% OwnerJul 06, 2016 Buy$12.50120,0001,500,000628,566Jul 06, 2016, 11:54 AM
Flynn James E10% OwnerJul 06, 2016 Buy$12.50280,0003,500,0001,466,654Jul 06, 2016, 11:54 AM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
AKKARAJU SRINIVASDirector12/21/20233,999,998
Roth DavidChief Medical Officer12/12/202331,121
Roth DavidChief Medical Officer12/06/202324,834
Simonian Nancy APresident & CEO11/01/202329,750
Haas JasonChief Financial Officer11/01/202313,988
Roth DavidChief Medical Officer11/01/202313,988
Stephens KristinChief Development Officer11/01/202312,601
Chee ConleyChief Commercial Officer11/01/202313,329
Quirk Gerald EChief Legal & Compliance Offic10/19/202314,484
Roth DavidChief Medical Officer07/31/202329,025
Olson Eric RChief Scientific Officer07/17/20232,412
Haas JasonChief Financial Officer04/03/20231,607
Chee ConleyChief Commercial Officer04/03/20231,698
Roth DavidChief Medical Officer04/03/20231,607
Stephens KristinChief Development Officer04/03/20231,607
Olson Eric RChief Scientific Officer04/03/20231,607
Simonian Nancy APresident & CEO04/03/20234,778
TYSON TIMOTHYDirector09/30/202289,186
TYSON TIMOTHYDirector09/29/202216,770
Stephens KristinChief Development Officer04/01/202215,809
Roth DavidChief Medical Officer04/01/202230,555
Olson Eric RChief Scientific Officer04/01/202230,538
Simonian Nancy APresident & CEO04/01/202265,949
Olson Eric RChief Scientific Officer01/05/20227,655
Olson Eric RChief Scientific Officer07/01/20216,460
Olson Eric RChief Scientific Officer03/15/20213,664
Olson Eric RChief Scientific Officer03/15/202134,372
Young Richard ADirector02/16/202145,188
Young Richard ADirector02/08/202148,900
Young Richard ADirector11/17/202046,874
Young Richard ADirector11/16/20205,684
Simonian Nancy APresident & CEO12/18/2020203,612
Young Richard ADirector11/17/202046,874
Young Richard ADirector11/16/20205,684
Young Richard ADirector10/19/202049,639
Young Richard ADirector10/15/20202,774
Young Richard ADirector09/15/202062,236
Olson Eric RChief Scientific Officer08/18/202010,895
Olson Eric RChief Scientific Officer08/17/20205,013
Olson Eric RChief Scientific Officer08/17/202064,519
Olson Eric RChief Scientific Officer08/18/2020140,231
Young Richard ADirector08/17/202075,414
AKKARAJU SRINIVASDirector08/18/20202,076,724
AKKARAJU SRINIVASDirector08/17/20209,672
Young Richard ADirector07/15/202070,982
Olson Eric RChief Scientific Officer07/07/202020,538
AKKARAJU SRINIVASDirector07/01/202050,966
AKKARAJU SRINIVASDirector06/25/2020612,850
AKKARAJU SRINIVASDirector06/24/2020539,788
AKKARAJU SRINIVASDirector06/23/2020565,930
Young Richard ADirector06/15/202052,413
Young Richard ADirector05/15/202055,242
Alles Mark JDirector05/13/202088,590
Young Richard ADirector04/15/2020209,650
Olson Eric RChief Scientific Officer02/18/202010,674
Simonian Nancy APresident & CEO12/23/2019159,299
Springhorn Jeremy P.Chief Business Officer11/11/201949,328
Springhorn Jeremy P.Chief Business Officer11/12/201950,268
Young Richard ADirector08/16/2019227,000
Young Richard ADirector08/15/201923,000
ARCH Venture Fund VII, L.P.10% Owner07/17/2019265,687
ARCH Venture Fund VII, L.P.10% Owner07/16/2019201,277
ARCH Venture Fund VII, L.P.10% Owner07/15/201922,316
AKKARAJU SRINIVASDirector04/09/20193,999,990
ARCH Venture Fund VII, L.P.10% Owner03/14/2019350,441
ARCH Venture Fund VII, L.P.10% Owner03/13/2019666,565
ARCH Venture Fund VII, L.P.10% Owner03/12/2019295,374
ARCH Venture Fund VII, L.P.10% Owner03/11/2019291,366
ARCH Venture Fund VII, L.P.10% Owner03/08/2019585,270
ARCH Venture Fund VII, L.P.10% Owner03/07/2019242,013
Simonian Nancy APresident & CEO11/29/2018136,224
AKKARAJU SRINIVASDirector01/31/20181,999,999
Springhorn Jeremy P.Chief Business Officer12/15/2017136,260
AKKARAJU SRINIVASDirector12/14/2017239,134
AKKARAJU SRINIVASDirector12/13/2017613,548
AKKARAJU SRINIVASDirector12/12/2017138,876
DeSimone Colleen ElizabethPrincipal Accounting Officer10/23/20171,672
DeSimone Colleen ElizabethPrincipal Accounting Officer10/23/20178,833
Young Richard ADirector08/14/201772,204
Olson Eric RChief Scientific Officer08/07/20172,525
Olson Eric RChief Scientific Officer08/07/201758,969
Olson Eric RChief Scientific Officer07/25/201712,625
Olson Eric RChief Scientific Officer07/25/2017273,125
Young Richard ADirector07/25/201772,496
Nashat AmirDirector07/06/20165,000,000
Polaris Management Co. VII, L.L.C.10% Owner07/06/20165,000,000
Flagship Ventures Fund IV, L.P.10% Owner07/06/20165,000,000
Redmile Group, LLC10% Owner07/06/20165,409,325
Arch Venture Fund VII LP10% Owner07/06/20165,000,000
NELSEN ROBERTDirector07/06/20165,000,000
AISLING CAPITAL III LP10% Owner07/06/20165,000,000
Flynn James E10% Owner07/06/20161,500,000
Flynn James E10% Owner07/06/20163,500,000
Load More Insider Transactions
FUNDS WITH A POSITION IN SYROS PHARMACEUTICALS INC.
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
ADAGE CAPITAL PARTNERS GP, L.L.C.2,071,9140.03%187%Other
BLACKROCK INC.246,9440.00005%0.49%Other
GEODE CAPITAL MANAGEMENT, LLC161,5630.00013%17.19%Other
UBS OCONNOR LLC130,0000.07%NewValue
RENAISSANCE TECHNOLOGIES LLC58,6350.00071%19.09%Other
CHANGE IN SHARES OUTSTANDING FOR SYROS PHARMACEUTICALS INC.
STOCK BUYBACKS FOR SYROS PHARMACEUTICALS INC.
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
5.59%
1Q
12/31/2023
06/30/2023
5.88%
2Q
12/31/2023
03/31/2023
6.15%
3Q

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
5.59%
1Q
06/30/2023
5.88%
2Q
03/31/2023
6.15%
3Q
BUYBACK ANNOUNCEMENT(S) FOR SYROS PHARMACEUTICALS INC.
LOADING...